Results 31 to 40 of about 55,084 (174)

Burden of Influenza and Cost‐Effectiveness Analysis of Introduction of an Influenza Vaccination Programme Among Older Adults in India

Influenza and Other Respiratory Viruses, Volume 20, Issue 5, May 2026.
ABSTRACT Background In India, no publicly funded seasonal influenza immunization is ongoing, partly because cost‐effectiveness is yet to be established. We estimate the cost‐effectiveness and budgetary impact of introducing seasonal influenza vaccination among adults aged ≥ 60 years in India, a known high‐risk group. Methods Estimates of disease burden
Anand Krishnan, Aslesh Ottapura Prabhakaran, Kusum Shekhawat, Ismael R. Ortega‐Sanchez, Rakesh Kumar, Ritvik Amarchand, Prabu Rajkumar, Suman Kanungo, Sumit Dutt Bhardwaj, Giridara Gopal, Girish Kumar Chethrapilly Purushothaman, Varsha Potdar, Alok Kumar Chakrabarti, Radhika Gharpure, Avinash Choudekar, Kathryn E. Lafond, Lalit Dar, Siddhartha Saha, Kathrine R. Tan, Eduardo Azziz‐Baumgartner   +19 more
wiley   +1 more source

The Epidemiology of Sickle Cell Disease in Sub‐Saharan Africa: Current Knowledge and Gaps to be Filled

American Journal of Hematology, Volume 101, Issue S1, Page 5-16, April 2026.
What are the available data on incidence & prevalence prognosis risk factors of severity of sickle cell disease in sub‐Saharan Africa? ABSTRACT Sickle Cell Disease (SCD) is highly prevalent in sub‐Saharan Africa. Epidemiological data remain sparse, but regional screening and research initiatives are expanding.
Brigitte Ranque, Leon Tshilolo, Thomas N. Williams   +2 more
wiley   +1 more source

Why, Immunologically, Housing‐Related Fungi and Endotoxins (and Other Chronic Pro‐Inflammatory Stressors) Risk Latent Tuberculosis Reactivation, Severe Asthma, and Translocating and Invasive Infections in Indigenous Communities in Canada

American Journal of Human Biology, Volume 38, Issue 4, April 2026.
ABSTRACT Type 1/M1/TH1 and type 3/M1/TH17 pro‐inflammatory switches are risks for latent Mycobacterium tuberculosis (Mtb) reactivation and ongoing infection transmission. This paper considers the heavy toll of reactivation risk in Indigenous communities in Canada and the chronic, everyday pro‐inflammatory stressors connected with type 3/M1/TH17 immune ...
Stacie Burke
wiley   +1 more source

Neonatal meningitis caused by streptococcus pneumonia in Iran [PDF]

, 2015
Meningitis, pneumonia, and sepsis in newborns and young infants ...
Alaee, E., Bakhtiari, M., Shaye, M.A., Shaye, Z.A.   +3 more
core  

Destroyed Lung Syndrome—A Devastating and Neglected Consequence of Pulmonary Tuberculosis: Case Series From a Low‐Resource Setting in Ghana

Clinical Case Reports, Volume 14, Issue 4, April 2026.
Post‐pulmonary TB destroyed lung syndrome. ABSTRACT Tuberculous destroyed lung syndrome is a devastating and often neglected sequela of pulmonary tuberculosis. It has significant adverse effects on the quality of life of affected patients. This case series aims to raise awareness among clinicians and to emphasize the need for multifaceted preventive ...
Prosper Adjei, Kingsley Owusu Manu, Samuel Kyeremeh Adjei, Theophilus Nyamekye Yeboah, Bridget Maame Kweenuwa Ansah, Daniel Kwabena Asare, Fatimata Musah, Safura Alhassan   +7 more
wiley   +1 more source

Microbial Etiology and Antimicrobial Resistance in Pneumonia Among Hospitalized Patients in Kazakhstan: A Systematic Review and Single‐Arm Meta‐Analysis of Prevalence Data

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims Pneumonia is an inflammatory condition of the lower respiratory tract, commonly caused by infection and associated with substantial morbidity and healthcare utilization. The burden of pneumonia on healthcare is exacerbated by limited data on pathogenic causes and associated antimicrobial resistance (AMR). Here, we conducted
Radmir Sarsenov, Maxim Solomadin, Alyona Lavrinenko, Vyacheslav Beloussov, Vitaliy Strochkov, Shynggys Orkara, Nurlan Sandybayev, Sergey Yegorov   +7 more
wiley   +1 more source

Mast Cells in Acute COVID‐19 Patients

Allergy, EarlyView.
Ilan Zaffran, Hadas Pahima, Eli Ben‐Chetrit, Amir Jarjoui, Ilaria Puxeddu, Carl Zinner, Joana Vitte, Alexandar Tzankov, Francesca Levi‐Schaffer   +8 more
wiley   +1 more source

Burden and Characteristics of Respiratory Syncytial Virus‐Associated Bronchiolitis in Hospitalized Infants in Italy: A Systematic Review

Immunity, Inflammation and Disease, Volume 14, Issue 4, April 2026.
This review highlights the significant burden of RSV‐associated bronchiolitis in Italian infants 0‐59 months. While RSV remains the primary pathogen, co‐infections and pandemic‐related factors have altered its epidemiological trends. ABSTRACT Background Respiratory syncytial virus (RSV) is the main cause of bronchiolitis in infants.
Angela Bechini, Cristina Salvati, Marco Del Riccio, Benedetta Bonito, Enrica Stancanelli, Mario Bruschi, Giulia Ionita, Johanna Iamarino, Davide Bentivegna, Primo Buscemi, Giulia Ciardi, Claudia Cosma, Lorenzo Stacchini, Manjola Bega, Annamaria Schirripa, Lorenzo Bertizzolo, Barbara Muzii, Maria Vittoria Azzi, Salvatore Parisi, Francesca Trippi, Paolo Bonanni, Sara Boccalini   +21 more
wiley   +1 more source

Pneumococcal (Pneumonia) Vaccines [PDF]

American Journal of Respiratory and Critical Care Medicine, 2020
Phalgoon, Shah, John R, Woytanowski, Anas, Hadeh, Marianna, Sockrider   +3 more
openaire   +2 more sources

Age at First RSV Hospitalisation and the Risk of Subsequent Bacterial Pneumonia

Acta Paediatrica, EarlyView.
Samuel Videholm, Karin Strandell, Maria Björmsjö, Andreas Tornevi, Sven Arne Silfverdal   +4 more
wiley   +1 more source